Abstract:Pulmonary administration is widely used for the treatment of lung diseases. The interaction between drug molecules and pulmonary surfactants affects the efficacy of the drug directly. The location and distribution of drug molecules in a model pulmonary surfactant monolayer under different surface pressures can provide vivid information on the interaction between drug molecules and pulmonary surfactants during the pulmonary administration. Ketoprofen is a nonsteroidal anti-inflammatory drug for pulmonary administration. The effect of ketoprofen molecules on the lipid monolayer containing 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) and 1,2-dipalmitoyl-sn-glycero-3-phospho-rac-glycerol (DPPG) is studied by surface pressure (pi)-area (A) isotherms and compressibility modulus (C-s(-1))-surface pressure (pi) isotherms. The location and distribution of ketoprofen molecules in a lipid monolayer under different surface pressures are explored by surface tension, density profile, radial distribution function (RDF), and the potential of mean force (PMF) simulated by molecular dynamics (MD) simulation. The introduction of ketoprofen molecules affects the properties of DPPC/DPPG monolayers and the location and distribution of ketoprofen molecules in monolayers with various surface pressures. The existence of ketoprofen molecules hinders the formation of liquid-condensed (LC) films and decreases the compressibility of DPPC/DPPG monolayers. The location and distribution of ketoprofen molecules in the lipid monolayer are affected by cation-pi interaction between the choline group of lipids and the benzene ring of ketoprofen, the steric hindrance of the lipid head groups, and the hydrophobicity of ketoprofen molecule itself, comprehensively. The contact state of lipid head group with water is determined by surface pressure, which affects the interaction between drug molecules and lipids and further dominates the location and distribution of ketoprofen in the lipid monolayer. This work confirms that ketoprofen molecules can affect the property and the inner structure of DPPC/DPPG monolayers during breathing. Furthermore, the results obtained using a mixed monolayer containing two major pulmonary surfactants DPPC/DPPG and ketoprofen molecules will be helpful for the in-depth understanding of the mechanism of inhaled administration therapy.

Experiments and modelling of pulmonary surfactant disruption by aerosolised compounds

Experiments and modelling of pulmonary surfactant disruption by aerosolised compounds

Study Interactions Between Inhaled Nanoparticles and Pulmonary Surfactant Using Molecular Dynamics Simulations

The effect of surfactants and film-forming polymers on pulmonary surfactant function measured in vitro is dose-rate dependent

Computational Investigations of the Interaction Between the Cell Membrane and Nanoparticles Coated with a Pulmonary Surfactant.

A theoretical study of chemical delivery within the lung using exogenous surfactant.

The role of surface charge in the interaction of nanoparticles with model pulmonary surfactants

Constrained drop surfactometry for studying adsorbed pulmonary surfactant at physiologically relevant high concentrations

Biophysicochemical interaction of a clinical pulmonary surfactant with nano-alumina

Alteration of biophysical activity of pulmonary surfactant by aluminosilicate nanoparticles

Interactions of Model Airborne Particulate Matter with Dipalmitoyl Phosphatidylcholine and a Clinical Surfactant Calsurf

Behavior of Microbubbles on Air-Aqueous Interfaces

Pulmonary surfactant inhibition of nanoparticle uptake by alveolar epithelial cells

Investigation of Drug for Pulmonary Administration-Model Pulmonary Surfactant Monolayer Interactions Using Langmuir-Blodgett Monolayer and Molecular Dynamics Simulation: A Case Study of Ketoprofen.

Molecular dynamics simulations as support for experimental studies on surfactant interfacial layers

Supported pulmonary surfactant bilayers on silica nanoparticles: Formulation, stability and impact on lung epithelial cells

Understanding the principle biophysics concepts of pulmonary surfactant in health and disease

Physicochemical studies of direct interactions between lung surfactant and components of electronic cigarettes liquid mixtures

High-throughput screening of respiratory hazards: Exploring lung surfactant inhibition with 20 benchmark chemicals

Sol-gel transition induced by alumina nanoparticles in a model pulmonary surfactant

Molecular Modeling of Nanoplastic Transformations in Alveolar Fluid and Impacts on the Lung Surfactant Film.